- Home
- NEGG vs XBIT Comparison
NEGG vs XBIT Comparison
Compare NEGG & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEGG | XBIT |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 73.2M |
| IPO Year | 2010 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NEGG | XBIT |
|---|---|---|
| Price | $49.15 | $2.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 109.0K | 48.6K |
| Earning Date | 04-24-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,313,127,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.32 | $2.09 |
| 52 Week High | $137.84 | $4.67 |
Technical Indicators
Market Signals| Indicator | NEGG | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 36.86 | 54.13 |
| Support Level | $50.00 | $2.40 |
| Resistance Level | $56.35 | $2.55 |
| Average True Range (ATR) | 3.91 | 0.09 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 11.59 | 80.77 |
Price Performance
Historical ComparisonAbout NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.